Stock Analysis·← Pickers

NRC

NRC Health

NRC Health (NRC) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 59.7, with 3/3 trend checks passing.

Price
$21.94
+0.28 (+1.29%)
Day range
$21.92–$22.59
52wk $11.01–$23.00
Volume
59.2K
Avg
Trend score
3/3
Uptrend
RSI (14)
59.7
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

NRC with MA50 and MA200

22.7719.9317.0914.2611.4208/0110/2701/2304/2007/16
NRC2025-08-012026-07-16
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$19.93+10.07% vs price
MA200
$17.11+28.24% vs price
RSI (14)
59.7Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
$14.71–$15.3729.9% below price · 2 touches
Support Quality
2 touches1.1× zone volume
Valuation

NRC valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

NRC analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for NRC

NRC Health (NRC) is still trading in a constructive trend overall. The latest available price is $21.94, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 10.1% and above the 200-day moving average by 28.2%.

Momentum and stretch context

NRC currently has an RSI reading of 59.7, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

For traders reviewing NRC next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.

Company profile

About NRC Health

National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Share dilution

NRC shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
21.8M
Since Jun 2019
-12.1%
Trend
Fewer shares outstanding (buybacks)
Historical shares-outstanding data from Financial Modeling Prep. NRC28 data points from Jun 2019 to Mar 2026.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Trent Green
Employees
357
Market cap
$494.5M
Beta
0.38
52-week range
$11.01 – $23.00
Dividend
Yes · $0.60
Exchange
NASDAQ
Country
US
IPO date
23 May 2013
ISIN
US6373722023
CUSIP
637372202
Company profile data from Financial Modeling Prep. NRC listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about NRC

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.

NRC Stock Analysis: Uptrend, above MA50 & MA200, RSI 60 | MyStockHarbor